Literature DB >> 2212676

Regulation of HLA class II molecule expressions by IFN-gamma. The signal transduction mechanism in glioblastoma cell lines.

N Nezu1, K Ryu, Y Koide, T O Yoshida.   

Abstract

We examined the signal transduction mechanism responsible for the IFN-gamma-induced HLA class II molecule expressions on glioblastoma cell lines, T98G and A172. A series of experiments demonstrated that the activation of protein kinase C (PKC) is involved in the DR and DP molecule expressions on T98G cells. In addition to the activation of PKC, calcium influx appeared to be involved in the DR and DP molecule expressions on T98G. Northern blot analyses with actinomycin D or cycloheximide revealed that these second messengers induce the transcription of DRA and B and DPA and B genes without de novo protein synthesis. Furthermore, we examined the region of the DPB gene that is responsible for IFN-gamma-induced gene transcription by gene transfer of a series of 5' and 3' deletion mutants in which the upstream region of the DPB was linked to a reporter gene, chloramphenicol acetyltransferase. By using these deletion mutants, it appeared that the region between -152 and -126 bp contains a critical IFN-gamma-responsive element. Taken together, these results suggest that IFN-gamma activates PKC and stimulates calcium influx, resulting in the induction of transcription of DRA and B and DPA and B genes without de novo protein synthesis. In DPB gene, we speculate that preexiting protein(s) phosphorylated by PKC in the presence of Ca2+ might directly bind or indirectly interact with the region between -152 and -126 bp of the upstream sequence, leading to the induction of the transcription (possibly in concert with other nuclear protein(s) bound to the promoter sequences).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2212676

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  The signal transduction mechanism responsible for gamma interferon-induced indoleamine 2,3-dioxygenase gene expression.

Authors:  Y Koide; A Yoshida
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

2.  Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors.

Authors:  R H See; A W Chow
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Stimulatory effect of interleukin-1 beta on the interferon-gamma-dependent HLA-DR production.

Authors:  T Tomoda; T Kurashige; T Taniguchi
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

4.  Two cis-DNA elements involved in myeloid-cell-specific expression and gamma interferon (IFN-gamma) activation of the human high-affinity Fc gamma receptor gene: a novel IFN regulatory mechanism.

Authors:  C Perez; J Wietzerbin; P D Benech
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

5.  Delineation of a previously unrecognized cis-acting element required for HLA class II gene expression.

Authors:  M Sugawara; P D Ponath; J Shin; Z Yang; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

6.  Role of protein kinase C activation in synthesis of complement components C2 and factor B in interferon-gamma-stimulated human fibroblasts, glioblastoma cell line A172 and monocytes.

Authors:  I Watanabe; T Horiuchi; S Fujita
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

7.  A 2-Gene Signature Related to Interferon-Gamma Predicts Prognosis and Responsiveness to Immune Checkpoint Blockade of Glioma.

Authors:  Yongzhe Li; Hang Ji; Xin Gao
Journal:  Front Med (Lausanne)       Date:  2022-04-15

8.  Dissection of the interferon gamma-MHC class II signal transduction pathway reveals that type I and type II interferon systems share common signalling component(s).

Authors:  J E Loh; C H Chang; W L Fodor; R A Flavell
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

9.  Establishment of an enzyme immunoassay using monoclonal antibody (HG1-219) and its application for the diagnosis of hepatocellular carcinoma.

Authors:  T Hada; Y Kinoshita; Y Ichimori; H Imanishi; K Umeyama; Y Amuro; A Toyosaka; E Okamoto; K Higashino
Journal:  Jpn J Cancer Res       Date:  1992-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.